• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
HU Yue, CHEN Zhou, LUO Xiaoxing, XUE Xiaoyan. Research progress of 1, 2-dilinoleyloxy-3-dimethylaminopropane-based cationic lipid nanoparticle[J]. Journal of China Pharmaceutical University, 2016, 47(1): 112-117. DOI: 10.11665/j.issn.1000-5048.20160117
Citation: HU Yue, CHEN Zhou, LUO Xiaoxing, XUE Xiaoyan. Research progress of 1, 2-dilinoleyloxy-3-dimethylaminopropane-based cationic lipid nanoparticle[J]. Journal of China Pharmaceutical University, 2016, 47(1): 112-117. DOI: 10.11665/j.issn.1000-5048.20160117
shu

Research progress of 1, 2-dilinoleyloxy-3-dimethylaminopropane-based cationic lipid nanoparticle

More Information
    Graphical Abstract
    • Abstract
  • Cationic lipid nanoparticles possessing favorable biocompatibility and controllable particle size have attracted increasing attention in the field of non-viral vectors for delivering nucleic acids in vitro and in vivo. 1, 2-Dilinoleyloxy-3-dimethylaminopropane(DLinDMA)and its derivatives, one kind of most important cationic lipid materials, have been widely studied as the main composition of cationic lipid nanoparticles. This paper summarizes the structure, characteristics and clinical application of DLinDMA nanoparticles.
    • FullText(HTML)
    • References (15)
  • [1]
    Bai H.Design,synthesis and antibacterial activity of antisense peptide nucleic acid targeting bacterial RNA polymerase primary σ70[D].Xi′an:the Fourth Military Medical University,2011.
    [2]
    Zimmermann TS, Lee AC, Akinc A, et al. RNAi-mediated gene silencing in non-human primates[J].Nature,2006,441(7089):111-114.
    [3]
    Semple SC,Akinc A,Chen J,et al.Rational design of cationic lipids for siRNA delivery[J].Nat Biotechnol,2010,28(2):172-176.
    [4]
    Miller AD.Delivery of RNAi therapeutics:work in progress[J].Expert Rev Med Devices,2013,10(6):781-811.
    [5]
    Zhou YD,Li J.Cationic liposome used as gene vector:materials and preparation techniques[J].Prog Pharm Sci(药学进展),2009,33(7):297-304.
    [6]
    Kanasty R, Dorkin JR, Vegas A, et al. Delivery materials for siRNA therapeutics[J].Nat Mater,2013,12(11):967-977.
    [7]
    Miller AD.Delivering the promise of small ncRNA therapeutics[J].Ther Deliv,2014, 5(5):569-589.
    [8]
    Kolli S,Wong SP,Harbottle R,et al.pH-triggered nanoparticle mediated delivery of siRNA to liver cells in vitro and in vivo[J].Bioconjug Chem,2013, 24(3):314-332.
    [9]
    Kenny GD,Kamaly N,Kalber TL,et al.Novel multifunctional nanoparticle mediates siRNA tumour delivery,visualisation and therapeutic tumour reduction in vivo[J].J Control Release,2011, 149(2):111-116.
    [10]
    Medina-Kauwe LK,Xie J,Hamm-Alvarez S.Intracellular trafficking of nonviral vectors[J].Gene Ther,2005, 12(24):1734-1751.
    [11]
    Kang MR,Yang G,Place RF,et al.Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth[J].Cancer Res,2012, 72(19):5069-5079.
    [12]
    Guo J,Cahill MR,McKenna SL,et al.Biomimetic nanoparticles for siRNA delivery in the treatment of leukaemia[J].Biotechnol Adv,2014, 32(8):1396-1409.
    [13]
    Kajimoto K,Sato Y,Nakamura T,et al.Multifunctional envelope-type nano device for controlled intracellular trafficking and selective targeting in vivo[J].J Control Release,2014,190:593-606.
    [14]
    Haynes M,Huang L.Hepatic RNA interference:delivery by synthetic vectors[J].Drug Deliv Transl Res,2014,4(1):61-73.
    [15]
    Hobo W,Novobrantseva TI,Fredrix H,et al.Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation[J].Cancer Immunol Immunother,2013, 62(2):285-297.
    • Related Articles

  • Related Articles

    [1]ZHAO Xiujuan, YANG Hengli, WU Jinye, ZHENG Xiaoqi, ZHANG Yaoping, LIN Yuping, HU Chunyan. Synthesis and anti-inflammatory activity of three series of coumarin-based derivatives[J]. Journal of China Pharmaceutical University, 2025, 56(1): 40-48. DOI: 10.11665/j.issn.1000-5048.2024072101
    [2]SHEN Yunhong, CHEN Hongjie, MAO Zewei, HUANG Zhengxiao, HU Chunyan. Synthesis and antifungal evaluation of chalcone derivatives combined with fluconazole against drug-resistant Candida albicans[J]. Journal of China Pharmaceutical University, 2023, 54(5): 564-568. DOI: 10.11665/j.issn.1000-5048.2023041002
    [3]WANG Mengxiao, MA Lingman, LIU Hanhan, JIANG Meiling, DOU Jie, ZHOU Changlin. Effective antimicrobial activity of Cbf-14-2 against penicillin-resistant bacteria in vitro and in vivo[J]. Journal of China Pharmaceutical University, 2017, 48(4): 496-502. DOI: 10.11665/j.issn.1000-5048.20170416
    [4]TANG Yong, LIAO Shengrong, LI Jinsheng, LIU Yonghong. Design, synthesis and cytotoxic activities of fluorine-containing 2, 5-diketopiperazine derivatives[J]. Journal of China Pharmaceutical University, 2016, 47(4): 412-421. DOI: 10.11665/j.issn.1000-5048.20160405
    [5]ZHANG Qian, CHEN Cen, YANG Fengqing, XIA Zhining. Mechanism of agonist-induced platelet activation and research progress of anti-platelet drugs[J]. Journal of China Pharmaceutical University, 2014, 45(6): 632-648. DOI: 10.11665/j.issn.1000-5048.20140604
    [6]LI Bing, LI Bo, ZHOU Changlin. Progress on antimicrobial peptides against drug-resistant bacterial infection[J]. Journal of China Pharmaceutical University, 2014, 45(5): 580-586. DOI: 10.11665/j.issn.1000-5048.20140514
    [7]WU Mingming, FANG Lei, GOU Shaohua, CHEN Li. 以2-甲基-2-取代苯氧基丙酸为离去基团的铂(Ⅱ)配合物的合成、表征及细胞毒活性[J]. Journal of China Pharmaceutical University, 2013, 44(4): 303-306. DOI: 10.11665/j.issn.1000-5048.20130403
    [8]Advances in the research of anti-tuberculosis drugs[J]. Journal of China Pharmaceutical University, 2010, 41(4): 299-305.
    [9]MIAO You-pan, LI Ai-xiu, LIU Tao, WU Ke-zhu. Molecular designing strategies of anti-drug-resistant HIV-1 protease inhibitors[J]. Journal of China Pharmaceutical University, 2009, 40(3): 279-283.
    [10]Structure-Cytotoxic Activity Relationships of Diterpenoid Tanshinones from Salvias[J]. Journal of China Pharmaceutical University, 2002, (1): 8-14.

Catalog

    Get Citation
    PDF
    XML
    Article views (1481) PDF downloads (2218) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：302623

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return